Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Characteristics and Predictors of Early Deaths in Newly Diagnosed Classical Hodgkin Lymphoma

Cong Sun, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 1671.

https://doi.org/10.1182/blood-2024-208102

Published: 2024

Journal Articles

Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with Brentuximab Vedotin (BV)-Based Treatment Options in China

Hengge Xu, Wei Li, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 6537.

https://doi.org/10.1182/blood-2024-207221

Published: 2024

Journal Articles

Analysis of the Nervous System Adverse Events Associated with Blinatumomab: A Real-World Study Using the FDA Adverse Event Reporting System Database

Wen Gao, Yaxiao Lu, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 2355.

https://doi.org/10.1182/blood-2024-201919

Published: 2024

Journal Articles

Phosphorylation-Dependent ANXA2 Relocation on the Membrane and TLR4 Engagement: A Novel Signaling Axis Promoted By PIM1 Mutation in Diffuse Large B Cell Lymphoma

Yaxiao Lu, Ning Zhang, Yidan Zhang, Xiyue Xu, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 2962.

https://doi.org/10.1182/blood-2024-206311

Published: 2024

Journal Articles

Magnesium Is Associated with Favorable Outcomes of Cancer Patients Treated with Immune Checkpoint Inhibitors

Yingfang Feng, Meng Gao, Hengqi Liu, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 6365.

https://doi.org/10.1182/blood-2024-202291

Published: 2024

Journal Articles

Exploring the Molecular Landscape of Follicular Lymphoma Histologic Grading: Insights from Genomic and Transcriptome Analyses

Huilai Zhang, Cong Sun, Xianhuo Wang

Blood (2024) 144 (Supplement 1): 6214.

https://doi.org/10.1182/blood-2024-201527

Published: 2024

Journal Articles

Selinexor Induces DLBCL Cell Senescence Mediated By USP1/MDMX/p53 Axis

Yidan Zhang, Xiyue Xu, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 4174.

https://doi.org/10.1182/blood-2024-201248

Published: 2024

Journal Articles

Clinical Features of Cutaneous T-Cell Lymphoma and the Application of Anti-PD-1 Antibodies in Relapsed /Refractory Patients

Junlei Jia, Yifei Sun, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 6409.

https://doi.org/10.1182/blood-2024-207103

Published: 2024

Journal Articles

Risk Stratification for Diffuse Large B-Cell Lymphoma Integrating Interim 18 f-FDG PET-CT Analysis and the National Comprehensive Cancer Network IPI: A Multicentre Retrospective Study

Jiesong Wang, Xianhuo Wang, Huilai Zhang

Blood (2024) 144 (Supplement 1): 6432.

https://doi.org/10.1182/blood-2024-202458

Published: 2024

Journal Articles

Integrative Genomic and Transcriptomic Analysis Reveals Genetic Alterations Associated with the Early Progression of Follicular Lymphoma

Fenghua Gao, Hengqi Liu, Xianhuo Wang, Yixin Yao, Huilai Zhang

Blood (2023) 142 (Supplement 1): 3022.

https://doi.org/10.1182/blood-2023-174182

Published: 2023

Journal Articles

Preclinical Efficacy and Mechanism for a Novel BTK-Protacs Against Mantle Cell Lymphoma

Yue Fei, Xiaohui Wang, Shangzhe Yu, Yixin Yao, Guisen Zhao, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 2267.

https://doi.org/10.1182/blood-2023-185275

Published: 2023

Journal Articles

Azacitidine for Injection Combined with Chidamide in Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase I Study

Jingwei Yu, Yaxiao Lu, Yixin Yao, Xianming Liu, Lanfang Li, Zhengzi Qian, Lihua Qiu, Shiyong Zhou, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 3076.

https://doi.org/10.1182/blood-2023-188801

Published: 2023

Journal Articles

CD58 Genetic Alterations and Its Contribution to Upregulation of PD-L1 and IDO Via LYN/CD22/SHP1 Axis in DLBCL

Xiyue Xu, Qingpei Guan, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Yixin Yao, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 524.

https://doi.org/10.1182/blood-2023-188468

Published: 2023

Journal Articles

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

Fenghua Gao, Jing Liu, Jiesong Wang, Lihong Liu, Zhiming Li, Yuqin Song, Xudong Zhang, Hui Zhou, Xiuhua Sun, Wei Zhang, Bing Xu, Liping Su, Wen Shujuan, Rong Tao, Ou Bai, Qingyuan Zhang, Liqun Zou, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2023-174308

Published: 2023

Journal Articles

A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses

Huilai Zhang, Liping Su, Lihong Liu, Ou Bai, Zheng Song, Zhiqiang Zhao, Cuiying He, Qiang Guo, Xianhuo Wang, Wei Li, Lihua Qiu, Lanfang Li, Shiyong Zhou, Yue Fei, Xiaohui Wang, Bin Meng

Blood (2023) 142 (Supplement 1): 736.

https://doi.org/10.1182/blood-2023-178509

Published: 2023

Journal Articles

YAP1-Dependent Promotion of Downstream Transcription through BRD4 Mediates Selinexor Resistance in Diffuse Large B-Cell Lymphoma

Xiaoxuan Wang, Yidan Zhang, Xianyou Xia, Yixin Yao, Xudong Wu, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 2823.

https://doi.org/10.1182/blood-2023-185242

Published: 2023

Journal Articles

A Prospective Phase II Study of Radiotherapy Followed By Tiselizumab Combined with R-CHOP in the Untreated Follicular Lymphoma Patients with Bulky Disease in China

Wei Li, Ximei Zhang, Fenghua Gao, Yixin Yao, Xianhuo Wang, Huilai Zhang

Blood (2023) 142 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2023-185752

Published: 2023

Journal Articles

PIM1 Genetic Alterations Associated with Distinct Molecular Profiles, Phenotypes and Drug Responses in Diffuse Large B-Cell Lymphoma

Xianhuo Wang, Yaxiao Lu, Sicong Zhang, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Kai Fu, Huilai Zhang

Blood (2022) 140 (Supplement 1): 9264–9265.

https://doi.org/10.1182/blood-2022-164976

Published: 2022

Journal Articles

Comprehensive Analysis of TP53 and CD58 Mutations and Identification of Patients with Inferior Prognosis and Enhanced Immune Escape in Diffuse Large B Cell Lymphoma

Xianhuo Wang, Tingting Zhang, Yaxiao Lu, Yue Fei, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Kai Fu, Huilai Zhang

Blood (2022) 140 (Supplement 1): 9236–9237.

https://doi.org/10.1182/blood-2022-164603

Published: 2022

Journal Articles

Immune Checkpoints Involving the PD-1/PD-L1/L2 and CD73/A2aR Axes and the Immunosuppressive Microenvironment in DLBCL

Xianhuo Wang, Tingting Zhang, Hengqi Liu, Sicong Zhang, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Kai Fu, Huilai Zhang

Blood (2022) 140 (Supplement 1): 6458–6459.

https://doi.org/10.1182/blood-2022-165060

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Characteristics and Predictors of Early Deaths in Newly Diagnosed Classical Hodgkin Lymphoma

Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with Brentuximab Vedotin (BV)-Based Treatment Options in China

Analysis of the Nervous System Adverse Events Associated with Blinatumomab: A Real-World Study Using the FDA Adverse Event Reporting System Database

Phosphorylation-Dependent ANXA2 Relocation on the Membrane and TLR4 Engagement: A Novel Signaling Axis Promoted By PIM1 Mutation in Diffuse Large B Cell Lymphoma

Magnesium Is Associated with Favorable Outcomes of Cancer Patients Treated with Immune Checkpoint Inhibitors

Exploring the Molecular Landscape of Follicular Lymphoma Histologic Grading: Insights from Genomic and Transcriptome Analyses

Selinexor Induces DLBCL Cell Senescence Mediated By USP1/MDMX/p53 Axis

Clinical Features of Cutaneous T-Cell Lymphoma and the Application of Anti-PD-1 Antibodies in Relapsed /Refractory Patients

Risk Stratification for Diffuse Large B-Cell Lymphoma Integrating Interim 18 f-FDG PET-CT Analysis and the National Comprehensive Cancer Network IPI: A Multicentre Retrospective Study

Integrative Genomic and Transcriptomic Analysis Reveals Genetic Alterations Associated with the Early Progression of Follicular Lymphoma

Preclinical Efficacy and Mechanism for a Novel BTK-Protacs Against Mantle Cell Lymphoma

Azacitidine for Injection Combined with Chidamide in Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase I Study

CD58 Genetic Alterations and Its Contribution to Upregulation of PD-L1 and IDO Via LYN/CD22/SHP1 Axis in DLBCL

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis

A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses

YAP1-Dependent Promotion of Downstream Transcription through BRD4 Mediates Selinexor Resistance in Diffuse Large B-Cell Lymphoma

A Prospective Phase II Study of Radiotherapy Followed By Tiselizumab Combined with R-CHOP in the Untreated Follicular Lymphoma Patients with Bulky Disease in China

PIM1 Genetic Alterations Associated with Distinct Molecular Profiles, Phenotypes and Drug Responses in Diffuse Large B-Cell Lymphoma

Comprehensive Analysis of TP53 and CD58 Mutations and Identification of Patients with Inferior Prognosis and Enhanced Immune Escape in Diffuse Large B Cell Lymphoma

Immune Checkpoints Involving the PD-1/PD-L1/L2 and CD73/A2aR Axes and the Immunosuppressive Microenvironment in DLBCL

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only